About Harvard Bioscience
Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company's products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world. The Company's core product range is organized into five product families: Fluidics, Lab Equipment and Supplies, Molecular Analysis, Cell Physiology and Animal Physiology. Its products include instruments, consumables, and systems that are made up of several individual products. The Company's brands include Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company has sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada and China.
Industry, Sector and Symbol:
- Sector: Computer and Technology
- Industry: Medical Instruments & Supplies
- Sub-Industry: Life Sciences Tools & Services
- Exchange: NASDAQ
- Symbol: HBIO
- CUSIP: 41690610
Key Metrics:
- Previous Close: $2.88
- 50 Day Moving Average: $2.67
- 200 Day Moving Average: $2.96
- 52-Week Range: $34,313,000.00 - $2.41
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 12.52
- P/E Growth: 1.78
- Market Cap: $98.82M
- Outstanding Shares: 34,313,000
- Beta: 0.95
Profitability:- Net Margins: -18.04%
- Return on Equity: 3.40%
- Return on Assets: 2.29%
Debt:- Debt-to-Equity Ratio: 0.18%
- Current Ratio: 3.15%
- Quick Ratio: 1.66%
Additional Links:
Companies Related to Harvard Bioscience:
Consensus Ratings for Harvard Bioscience (NASDAQ:HBIO) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | 1 Buy Rating |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $6.00 (108.33% upside) |
Analysts' Ratings History for Harvard Bioscience (NASDAQ:HBIO)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 10/30/2015 | Benchmark Co. | Lower Price Target | Buy | $8.00 -> $6.00 |  |
(Data available from 9/26/2014 forward)
Earnings History for Harvard Bioscience (NASDAQ:HBIO)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/27/2016 | | | | | | | | |
| 7/28/2016 | Q2 | $0.03 | $0.03 | $26.60 million | $26.10 million | View | Listen | |
| 5/12/2016 | Q1 | $0.02 | $0.05 | $26.00 million | $27.00 million | View | Listen | |
| 4/29/2016 | Q4 | $0.03 | $0.03 | | | View | N/A | |
| 10/29/2015 | Q315 | $0.05 | $0.03 | $27.01 million | $25.70 million | View | Listen | |
| 7/30/2015 | Q215 | $0.04 | $0.05 | $26.60 million | $28.80 million | View | Listen | |
| 4/30/2015 | Q414 | $0.05 | $0.01 | $27.15 million | $25.80 million | View | Listen | |
| 2/26/2015 | Q314 | $0.09 | $0.10 | $29.30 million | $30.40 million | View | N/A | |
| 10/30/2014 | Q214 | $0.06 | $0.06 | $25.46 million | $25.40 million | View | N/A | |
| 7/31/2014 | Q2 | $0.05 | $0.05 | | | View | N/A | |
| 5/1/2014 | Q114 | $0.03 | $0.05 | $26.10 million | $25.90 million | View | N/A | |
| 2/27/2014 | Q413 | ($0.02) | $0.05 | $28.20 million | $27.90 million | View | N/A | |
| 10/31/2013 | Q313 | $0.01 | $0.05 | $26.10 million | $25.10 million | View | N/A | |
| 5/2/2013 | Q1 2013 | | $0.08 | $28.30 million | $26.10 million | View | N/A | |
| 11/1/2012 | Q312 | | $0.08 | $26.40 million | $26.10 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Harvard Bioscience (NASDAQ:HBIO)Current Year EPS Consensus Estimate: $0.16 EPS
Next Year EPS Consensus Estimate: $0.23 EPS
Dividend History for Harvard Bioscience (NASDAQ:HBIO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Harvard Bioscience (NASDAQ:HBIO)Insider Ownership Percentage: 8.80%
Institutional Ownership Percentage: 66.31%
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 12/10/2015 | Jeffrey Duchemin | CEO | Buy | 10,000 | $3.37 | $33,700.00 | |
| 12/3/2015 | George Uveges | Director | Buy | 3,000 | $3.32 | $9,960.00 | |
| 11/9/2015 | Robert E Gagnon | CFO | Buy | 3,000 | $3.08 | $9,240.00 | |
| 9/2/2015 | Jeffrey Duchemin | CEO | Buy | 2,000 | $4.41 | $8,820.00 | |
| 9/1/2015 | John F Kennedy | Director | Buy | 2,000 | $4.33 | $8,660.00 | |
| 7/17/2015 | David Green | Director | Sell | 17,103 | $5.26 | $89,961.78 | |
| 7/14/2015 | David Green | Director | Sell | 51,597 | $5.28 | $272,432.16 | |
| 4/23/2015 | David Green | Director | Sell | 118,500 | $6.03 | $714,555.00 | |
| 4/22/2015 | David Green | Director | Sell | 123,997 | $6.23 | $772,501.31 | |
| 4/17/2015 | David Green | Director | Sell | 42,503 | $6.55 | $278,394.65 | |
| 4/14/2015 | David Green | Director | Sell | 80,168 | $6.61 | $529,910.48 | |
| 2/9/2015 | David Green | Director | Sell | 48,712 | $5.25 | $255,738.00 | |
| 12/30/2014 | David Green | Director | Sell | 16,173 | $5.25 | $84,908.25 | |
| 12/29/2014 | David Green | Director | Sell | 100,167 | $5.25 | $525,876.75 | |
| 12/22/2014 | David Green | Director | Sell | 80,202 | $5.02 | $402,614.04 | |
| 11/19/2014 | David Green | Director | Sell | 10,000 | $4.95 | $49,500.00 | |
| 10/31/2014 | David Green | Director | Sell | 117,654 | $4.97 | $584,740.38 | |
| 6/16/2014 | Robert E Gagnon | CFO | Buy | 5,000 | $3.86 | $19,300.00 | |
| 5/29/2014 | Neal J Harte | Director | Sell | 12,317 | $3.82 | $47,050.94 | |
| 4/9/2014 | David Green | Director | Sell | 27,540 | $4.47 | $123,103.80 | |
| 4/8/2014 | David Green | Director | Sell | 66,090 | $4.48 | $296,083.20 | |
| 4/3/2014 | David Green | Director | Sell | 63,501 | $4.63 | $294,009.63 | |
| 8/27/2013 | Chane Graziano | Major Shareholder | Buy | 60,000 | $5.00 | $300,000.00 | |
(Data available from 1/1/2013 forward)
Latest Headlines for Harvard Bioscience (NASDAQ:HBIO)| Date | Headline |
|---|
 | ETF’s with exposure to Harvard Bioscience, Inc. : September 9, 2016 (NASDAQ:HBIO)
www.capitalcube.com - September 9 at 5:09 PM |
 | Harvard Bioscience (HBIO): Moving Average Crossover Alert (NASDAQ:HBIO)
finance.yahoo.com - August 29 at 5:16 PM |
 | EXCLUSIVE: UW president lays out vision for Global Innovation Exchange (NASDAQ:HBIO)
www.bizjournals.com - August 17 at 5:36 PM |
| Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:HBIO)
www.capitalcube.com - August 11 at 5:38 PM |
| Harvard Bioscience reports 2Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - July 28 at 10:42 AM |
| 7:30 am Harvard Bioscience reports Q2; guides FY16 (NASDAQ:HBIO)
finance.yahoo.com - July 28 at 7:30 AM |
| ETF’s with exposure to Harvard Bioscience, Inc. : July 21, 2016 (NASDAQ:HBIO)
www.capitalcube.com - July 21 at 2:06 PM |
 | HARVARD BIOSCIENCE SCHEDULES SECOND QUARTER 2016 CONFERENCE CALL FOR JULY 28 AT 8 : 30 am et (NASDAQ:HBIO)
www.4-traders.com - July 18 at 5:34 PM |
| Harvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET (NASDAQ:HBIO)
finance.yahoo.com - July 18 at 4:30 PM |
| ETF’s with exposure to Harvard Bioscience, Inc. : July 1, 2016 (NASDAQ:HBIO)
www.capitalcube.com - July 1 at 6:17 PM |
| HARVARD BIOSCIENCE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:HBIO)
biz.yahoo.com - June 27 at 4:16 PM |
 | Broker Watchlist: Harvard Bioscience, Inc. (HBIO) - Share Trading News (NASDAQ:HBIO)
www.sharetrading.news - June 2 at 8:07 AM |
 | Harvard Bioscience to Attend The Benchmark Company, LLC One-on-One Conference in Milwaukee, Wisconsin on June 2, 2016 (NASDAQ:HBIO)
www.publicnow.com - May 31 at 6:42 AM |
| Next Weeks Broker Price Targets For Harvard Bioscience, Inc. (HBIO) - Share Trading News (NASDAQ:HBIO)
www.sharetrading.news - May 30 at 9:58 PM |
| Performance at a Glance on Harvard Bioscience Inc. (NASDAQ:HBIO) - HNN (NASDAQ:HBIO)
hintsnewsnetwork.com - May 29 at 1:52 PM |
| HARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi (NASDAQ:HBIO)
biz.yahoo.com - May 27 at 4:11 PM |
| Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:HBIO)
www.capitalcube.com - May 13 at 12:16 PM |
| Edited Transcript of HBIO earnings conference call or presentation 12-May-16 12:30pm GMT (NASDAQ:HBIO)
finance.yahoo.com - May 12 at 10:50 AM |
| Q4 2015 and Q1 2016 Harvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 8:30 AM |
| Q1 2016 Harvard Bioscience Inc Earnings Release - Before Market Open (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 7:07 AM |
| Harvard Bioscience Reports First Quarter 2016 Financial Results (NASDAQ:HBIO)
www.publicnow.com - May 12 at 6:27 AM |
| HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 6:24 AM |
| Harvard Bioscience reports 1Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - May 12 at 6:15 AM |
| Harvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements (NASDAQ:HBIO)
www.publicnow.com - May 4 at 4:20 PM |
| Harvard Bioscience Regains Compliance with NASDAQ’s Continued Listing Requirements (NASDAQ:HBIO)
finance.yahoo.com - May 4 at 4:15 PM |
 | Harvard Bioscience Reports Fourth Quarter And Year-End 2015 Results, Preliminary First Quarter 2016 Revenues And 2016 Financial Guidance (NASDAQ:HBIO)
www.thestreet.com - April 29 at 5:42 PM |
| Harvard Bioscience reports 4Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - April 29 at 5:07 PM |
 | Harvard Bioscience to delay 10-K filing, reports Preliminary Q4 revenue (NASDAQ:HBIO)
seekingalpha.com - March 28 at 6:55 PM |
| Harvard Bioscience: 1 Analysts Continue to rate NASDAQ:HBIO - Hints News Network (NASDAQ:HBIO)
hintsnewsnetwork.com - February 26 at 1:00 PM |
| Could Harvard Bioscience, Inc. Rise Even More? The Stock Had Another Big Increase Today - RiversideGazette.com (NASDAQ:HBIO)
www.riversidegazette.com - February 26 at 1:00 PM |
| Earnings Per Share Preview for Harvard Bioscience, Inc. (HBIO) - RiversideGazette.com (NASDAQ:HBIO)
www.riversidegazette.com - February 26 at 1:00 PM |
| Why Heartland Advisors Inc Reported Big Harvard Bioscience Inc Position? - fdanewsalert.com (NASDAQ:HBIO)
www.fdanewsalert.com - February 5 at 2:42 PM |
| Recent Broker Updates On Harvard Bioscience, Inc. (HBIO) - Risers & Fallers (NASDAQ:HBIO)
www.risersandfallers.com - February 3 at 2:04 PM |
| Latest Analysts Reports On Harvard Bioscience, Inc. (HBIO) - Risers & Fallers (NASDAQ:HBIO)
www.risersandfallers.com - January 26 at 2:01 PM |
| HARVARD BIOSCIENCE INC Financials (NASDAQ:HBIO)
finance.yahoo.com - December 8 at 1:17 PM |
| Falling Earnings Estimates Signal Weakness Ahead for Harvard Bioscience (HBIO) (NASDAQ:HBIO)
finance.yahoo.com - November 25 at 8:31 AM |
| Strong Revenue Growth in the $6 Billion Biological Sample Preparation Market (NASDAQ:HBIO)
finance.yahoo.com - November 13 at 9:20 AM |
| HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report (NASDAQ:HBIO)
biz.yahoo.com - November 5 at 5:58 PM |
| Edited Transcript of HBIO earnings conference call or presentation 29-Oct-15 12:30pm GMT (NASDAQ:HBIO)
finance.yahoo.com - October 29 at 9:58 AM |
| Harvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:HBIO)
biz.yahoo.com - October 29 at 8:30 AM |
| HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit (NASDAQ:HBIO)
biz.yahoo.com - October 29 at 7:17 AM |
| Q3 2015 Harvard Bioscience Inc Earnings Release - Before Market Open (NASDAQ:HBIO)
biz.yahoo.com - October 29 at 7:07 AM |
| Harvard Bioscience reports 3Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - October 29 at 7:03 AM |
 | Harvard Bioscience Reports Third Quarter 2015 Financial Results and Updates Outlook for Full-Year 2015 (NASDAQ:HBIO)
www.noodls.com - October 29 at 6:58 AM |
Harvard Bioscience (NASDAQ:HBIO) Chart for Monday, September, 26, 2016
